These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 15925117)
1. Cognitive ERPs are related to ApoE allelic variation in mildly cognitively impaired patients. Reinvang I; Espeseth T; Gjerstad L Neurosci Lett; 2005 Jul; 382(3):346-51. PubMed ID: 15925117 [TBL] [Abstract][Full Text] [Related]
2. Impact of APOE status on cognitive maintenance in healthy elderly persons. Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849 [TBL] [Abstract][Full Text] [Related]
3. Cognitive deficits in amyotrophic lateral sclerosis evaluated by event-related potentials. Ogawa T; Tanaka H; Hirata K Clin Neurophysiol; 2009 Apr; 120(4):659-64. PubMed ID: 19342291 [TBL] [Abstract][Full Text] [Related]
4. Mismatch negativity (MMN) in multiple sclerosis: an event-related potentials study in 46 patients. Jung J; Morlet D; Mercier B; Confavreux C; Fischer C Clin Neurophysiol; 2006 Jan; 117(1):85-93. PubMed ID: 16325469 [TBL] [Abstract][Full Text] [Related]
5. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E modulates auditory event-related potentials in healthy aging. Espeseth T; Rootwelt H; Reinvang I Neurosci Lett; 2009 Aug; 459(2):91-5. PubMed ID: 19409447 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E4 genotype is not associated with short-term cognition deficits during alcohol withdrawal. Wilhelm J; von Ahsen N; Frieling H; Hillemacher T; Bayerlein K; Bönsch D; Ziegenbein M; Kornhuber J; Bleich S Alcohol; 2005 Nov; 37(3):151-6. PubMed ID: 16713503 [TBL] [Abstract][Full Text] [Related]
8. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers. Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495 [TBL] [Abstract][Full Text] [Related]
9. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. Sager MA; Hermann B; La Rue A J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248 [TBL] [Abstract][Full Text] [Related]
10. Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers. O'Hara R; Schröder CM; Kraemer HC; Kryla N; Cao C; Miller E; Schatzberg AF; Yesavage JA; Murphy GM Neurology; 2005 Aug; 65(4):642-4. PubMed ID: 16116137 [TBL] [Abstract][Full Text] [Related]
11. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Martins CA; Oulhaj A; de Jager CA; Williams JH Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608 [TBL] [Abstract][Full Text] [Related]
12. Medical utility of apoe allele determination in assessing the need for antioxidant therapy. Dreon DM; Peroutkal SJ Med Hypotheses; 2001 Mar; 56(3):357-9. PubMed ID: 11359359 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer's disease and mild cognitive impairment. Bennys K; Portet F; Touchon J; Rondouin G J Clin Neurophysiol; 2007 Oct; 24(5):405-12. PubMed ID: 17912065 [TBL] [Abstract][Full Text] [Related]
14. Electrophysiological and information processing variability predicts memory decrements associated with normal age-related cognitive decline and Alzheimer's disease (AD). Hogan MJ; Carolan L; Roche RA; Dockree PM; Kaiser J; Bunting BP; Robertson IH; Lawlor BA Brain Res; 2006 Nov; 1119(1):215-26. PubMed ID: 16997285 [TBL] [Abstract][Full Text] [Related]
15. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease. Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538 [TBL] [Abstract][Full Text] [Related]
16. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis. Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153 [TBL] [Abstract][Full Text] [Related]
17. Plasma levels of apolipoprotein E and cognitive function in old age. Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173 [TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in Alzheimer's disease is modified by APOE genotype. van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691 [TBL] [Abstract][Full Text] [Related]
19. ApoE alleles and tau markers in patients with different levels of cognitive impairment. Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E and category fluency: evidence for reduced semantic access in healthy normal controls at risk for developing Alzheimer's disease. Rosen VM; Sunderland T; Levy J; Harwell A; McGee L; Hammond C; Bhupali D; Putnam K; Bergeson J; Lefkowitz C Neuropsychologia; 2005; 43(4):647-58. PubMed ID: 15716154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]